Eric Wei, Director at Caladrius Biosciences, Inc. (CLBS), sold 87,500 shares at $0.60 ($53K) on 2016-06-30, disclosed to the SEC on 2016-07-05.
Scheduled sale ($53k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.60 | 71,406 | $43K | 81.4% |
| 2 | $0.61 | 16,094 | $10K | 18.6% |
| Total | $0.60 avg | 87,500 | $53K | 100% |
| Filing → |
| CCCS | SELL | 2025-05-22 | $544.8M | — | Filing → |
| CCCS | SELL | 2025-03-04 | $867.7M | — | Filing → |
| CCCS | SELL | 2024-07-01 | $564.4M | — | Filing → |